Exact Mass: 249.07091259999999
Exact Mass Matches: 249.07091259999999
Found 135 metabolites which its exact mass value is equals to given mass value 249.07091259999999,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cysteinyl-Glutamine
C8H15N3O4S (249.07832299999998)
Cysteinyl-Glutamine is a dipeptide composed of cysteine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Glutaminylcysteine
C8H15N3O4S (249.07832299999998)
Glutaminylcysteine is a dipeptide composed of glutamine and cysteine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Cysteinyl-Gamma-glutamate
C8H15N3O4S (249.07832299999998)
Cysteinyl-Gamma-glutamate is a dipeptide composed of cysteine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Ala-Cys-Gly
C8H15N3O4S (249.07832299999998)
Cinchophen
M - Musculo-skeletal system > M04 - Antigout preparations > M04A - Antigout preparations > M04AC - Preparations with no effect on uric acid metabolism C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
N-[4-(2,4-DIMETHYL-1,3-THIAZOL-5-YL)PYRIMIDIN-2-YL]-N-HYDROXYIMIDOFORMAMIDE
C10H11N5OS (249.06842759999998)
6,7-dimethoxy-2-methylisoquinoline-1,3,4(2H)-trione
Di-Me ether,N-formyl-3-Amino-6,7-dihydroxy-2H-1-benzopyran-2-one
Cinchophen
M - Musculo-skeletal system > M04 - Antigout preparations > M04A - Antigout preparations > M04AC - Preparations with no effect on uric acid metabolism C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4523; ORIGINAL_PRECURSOR_SCAN_NO 4519 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4546; ORIGINAL_PRECURSOR_SCAN_NO 4543 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4500; ORIGINAL_PRECURSOR_SCAN_NO 4498 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4520; ORIGINAL_PRECURSOR_SCAN_NO 4516 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4555; ORIGINAL_PRECURSOR_SCAN_NO 4552 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4546; ORIGINAL_PRECURSOR_SCAN_NO 4545 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8905; ORIGINAL_PRECURSOR_SCAN_NO 8900 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8921; ORIGINAL_PRECURSOR_SCAN_NO 8919 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8942; ORIGINAL_PRECURSOR_SCAN_NO 8939 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8878; ORIGINAL_PRECURSOR_SCAN_NO 8876 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8996; ORIGINAL_PRECURSOR_SCAN_NO 8993 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8968; ORIGINAL_PRECURSOR_SCAN_NO 8966
Cys-gglu
C8H15N3O4S (249.07832299999998)
GGlu-Cys
C8H15N3O4S (249.07832299999998)
5-(3,4-Dimethoxy-phenyl)-isoxazole-3-carboxylic acid
2-chloro-3-morpholin-4-yl-quinoxaline
C12H12ClN3O (249.06688519999997)
4-phenoxypyridine-2-carboximidamide,hydrochloride
C12H12ClN3O (249.06688519999997)
2-METHYL-6-NITRO-IMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER
methyl 1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carboxylate
4-(chloromethyl)-1-(furan-2-ylmethyl)piperidine,hydrochloride
C11H17Cl2NO (249.06871320000002)
2-(3-hydroxyphenyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione
(2S)-4-(1,3-Dioxoisoindolin-2-yl)-2-hydroxybutanoic acid
3-AMINO-3-(4-TRIFLUOROMETHOXY-PHENYL)-PROPIONIC ACID
3-(4-Fluorophenyl)-5-methyl-4-isoxazolecarboxylic acid ethyl ester
2-CHLORO-N-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)ACETAMIDE
C12H12ClN3O (249.06688519999997)
6-Nitro-1H-benzimidazole-2-acetic acid ethyl ester
6-(1-chloroethyl)-2-N-phenyl-1,3,5-triazine-2,4-diamine
5-CHLORO-2-CYANOPHENYLBORONIC ACID NEOPENTYL GLYCOL ESTER
C12H13BClNO2 (249.07278180000003)
2-Isopropoxy-5-(trifluoromethyl)pyridine-3-boronic acid
C9H11BF3NO3 (249.07840420000002)
2-METHYL-2-(5-(TRIFLUOROMETHYL)PYRIDIN-2-YLOXY)PROPANOIC ACID
(4-CHLORO-PHENYL)-(4-TRIFLUOROMETHOXY-PHENYL)-METHANONE
C14H13ClFN (249.07205000000002)
4-(2-chloroquinazolin-4-yl)morpholine
C12H12ClN3O (249.06688519999997)
4-Chloro-2-(4-Morpholinyl)quinazoline
C12H12ClN3O (249.06688519999997)
ethyl 2-cyano-2-(4-methyl-3-nitropyridin-2-yl)acetate
2-(2-METHOXY-ETHYL)-1,3-DIOXO-2,3-DIHYDRO-1H-ISOINDOLE-5-CARBOXYLIC ACID
6-chloro-N-[(4-methoxyphenyl)methyl]pyrimidin-4-amine
C12H12ClN3O (249.06688519999997)
Benzoxiquine
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
6-(chloromethyl)-2-N-(4-methylphenyl)-1,3,5-triazine-2,4-diamine
3-AMINO-3-(2-TRIFLUOROMETHOXY-PHENYL)-PROPIONIC ACID
2-Chloro-6-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzonitrile
C12H13BClNO2 (249.07278180000003)
1-PYRIDIN-2-YL-[1,4]DIAZEPANE DIHYDROCHLORIDE
C10H17Cl2N3 (249.07994620000002)
5-methyl-7-(trifluoromethyl)-1,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxylic acid
5-NITROSPIRO[BENZIMIDAZOLE-2,1-CYCLOPENTANE] 1,3-DIOXIDE
N-(4-Chlorobenzyl)-2-fluorobenzylamine
C14H13ClFN (249.07205000000002)
2-Chloro-N-(4-fluorobenzyl)-4-Methylaniline
C14H13ClFN (249.07205000000002)
2-Chloro-N-(3-fluorobenzyl)-4-Methylaniline
C14H13ClFN (249.07205000000002)
2-Propenoic acid, 4-cyano[1,1-biphenyl]-4-yl ester
Clorprenaline hydrochloride
C11H17Cl2NO (249.06871320000002)
Clorprenaline hydrochloride is a β2-adrenergic receptor agonist that is implicated in bronchial expansion. Clorprenaline has the potential for asthma research[1][2].
1,3-DIHYDRO-α-HYDROXY-1,3-DIOXO-2H-ISOINDOLE-2-BUTANOIC ACID
N-Acetyl-S-(3-carboxy-1-methylpropyl)-L-cysteine
C9H15NO5S (249.06708999999998)
5-(1-METHYL-PYRROLIDIN-2-YL)-PYRIDIN-2-YLAMINEDIHYDROCHLORIDE
C10H17Cl2N3 (249.07994620000002)
2-Propoxy-5-(trifluoromethyl)pyridine-3-boronic acid
C9H11BF3NO3 (249.07840420000002)
2-bromo-N-tert-butyl-3,3-dimethylbutanamide
C10H20BrNO (249.07281700000001)
[2-(3-chloro-phenyl)-ethyl]-(4-fluoro-phenyl)-amine
C14H13ClFN (249.07205000000002)
5-(2,4-DIMETHYOXYPHENYL)-1,3-OXAZOLE-4-CARBOXYLIC ACID
Methyl 3-(aminomethyl)-4-(trifluoromethoxy)benzoate
1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-4-[4-(FLUORO)PHENYL]-3-PYRIDINECARBOXYLIC ACID
N1-(1-METHYL-3-PHENYL-1H-PYRAZOL-5-YL)-2-CHLOROACETAMIDE
C12H12ClN3O (249.06688519999997)
6-(chloromethyl)-N-(3-methylphenyl)-1,3,5-triazine-2,4-diamine
N-{2-hydroxy-5-nitrobenzylidene}cyclopropanecarbohydrazide
Ala-Cys-Gly
C8H15N3O4S (249.07832299999998)
A tripeptide composed of L-alanine, L-cysteine, and glycine joined in sequence by peptide linkages.
N-[(4-fluorophenyl)methyl]-2-thiophen-2-ylacetamide
N-[(2-chlorophenyl)methyl]-1-(4-fluorophenyl)methanamine
C14H13ClFN (249.07205000000002)
2-oxo-4-(4-propan-2-yl-1-pyridin-1-iumyl)-3H-thiazole-5-carboxaldehyde
C12H13N2O2S+ (249.06976980000002)
2-[(4-Methoxy-1-benzouran-5-carbonyl)amino]acetic acid
4,5-dehydroanhydrolycorine
{"Ingredient_id": "HBIN009997","Ingredient_name": "4,5-dehydroanhydrolycorine","Alias": "NA","Ingredient_formula": "C16H11NO2","Ingredient_Smile": "NA","Ingredient_weight": "249.26","OB_score": "NA","CAS_id": "212-38-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7921","PubChem_id": "NA","DrugBank_id": "NA"}
6,7-dimethoxy-n-methyl-3,4-dioxo-1(2h)-iso-quinolinone
{"Ingredient_id": "HBIN012082","Ingredient_name": "6,7-dimethoxy-n-methyl-3,4-dioxo-1(2h)-iso-quinolinone","Alias": "NA","Ingredient_formula": "C12H11NO5","Ingredient_Smile": "CN1C(=O)C2=CC(=C(C=C2C(=O)C1=O)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6259","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-[(2-carboxy-2-hydroxyethyl)sulfanyl]piperidine-2-carboxylic acid
C9H15NO5S (249.06708999999998)
(2s)-2-amino-3-(4-nitro-1h-indol-3-yl)propanoic acid
5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-1(19),2,4(8),9,13,15,17-heptaene
(2r,4s)-4-{[(2r)-2-carboxy-2-hydroxyethyl]sulfanyl}piperidine-2-carboxylic acid
C9H15NO5S (249.06708999999998)